Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Xcyte Digital Corp. Announces Closing of Webinar.net Asset Purchase (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Old API Wind-down Ltd - Ordinary Shares
ARLZQ
Healthcare
Drug Manufacturers - Major
Drug Manufacturers - Specialty & Generic
"Old API Wind-down Ltd, formerly Aralez Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in the acquisition, development, and commercialization of products primarily in cardiovascular, pain management and other specialty areas. Its key products include Fiorinal, Proferrin, Fibricor, Uracyst and Neovisc, Cambia and other marketed products. The company currently...
operates in two geographical markets, the United States and Canada. The firm generates most of its reven
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
OTCPK:ARLZQ - Post Discussion
Old API Wind-down Ltd - Ordinary Shares
> Encouraging...
New Post
View:
Discussion
List
(0)
•••
GoldenDilemma
X
View Profile
View Bullboard History
Post by
GoldenDilemma
on Jul 21, 2016 10:13pm
Encouraging...
https://t.co/dgB94gPEwZ
(23)
•••
AbNormAl
X
View Profile
View Bullboard History
Comment by
AbNormAl
on Jul 22, 2016 2:28pm
I might well be daft, but picked up a few more shares based on the hiring hoping the slumber is over.
(61)
•••
snootchybootchy
X
View Profile
View Bullboard History
Comment by
snootchybootchy
on Jul 22, 2016 4:58pm
Also encouraging that Aralez did not follow Valeant and Concordia down today, which tells me most Aralez investors are now going to hold and wait for news. Take a look at V.PDP, which has doubled in value within days of getting a Health Canada approval. T.TOS also gained 60% within a week of getting their FDA approval. I can't see why Aralez can't jump to $7.50 or $8.00
...more
(0)
•••
GoldenDilemma
X
View Profile
View Bullboard History
Comment by
GoldenDilemma
on Jul 22, 2016 10:05pm
Let's see how much momentum we can get.
(0)
•••
Bigboyone
X
View Profile
View Bullboard History
Comment by
Bigboyone
on Jul 25, 2016 9:49am
A very Bullish sign and good news for any ARALEZ shareholder, is the short interest has dropped from 4.4 million shares (June) to 2.6 million shares (July)and looks like its dropping further. The only ones who would be able to "Short" would be the institutional players anyhow, as the stock is under $5 bucks, and most average shareholders have the stock in "Street Name" (No
...more
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Undervalued Oil & Gas Play Readies for Strong H2 2024 with Canadian and US Assets
GameSquare Announces Preliminary Second Quarter 2024 Results
Brazilian Gold Project has First Pour, Remains on Track for Commercial Production in H2 2024
Lahontan Drills 41 metres 0.90 g/t Au Eq incl. 16.8 metres 1.41 g/t Au Eq at Santa Fe